Treatment-Resistant Depression Treatment | Turnwell
Skip to main content
TMS • Spravato • IV Ketamine • All 4 Locations

Treatment-Resistant Depression When Antidepressants Haven't Been Enough

TMS therapy for treatment-resistant depression at Turnwell Mental Health

If two or more antidepressants have not worked, you are not alone and you are not out of options. About 30 percent of people with major depression do not respond to standard medications. That is a clinical reality, not a personal failure. Turnwell works specifically with this population, offering TMS therapy and Spravato at all four locations and IV ketamine at our Tampa Bay location.

TMS, Spravato & Ketamine AvailableCovered by Most Major InsuranceBoard-Certified Psychiatric Team
Turnwell Mental Health
Board-Certified Psychiatrists
Medicare, Medicaid & Most Insurance
4 Locations + Telehealth
Accepting New Patients
Understanding TRD

What Makes Depression Treatment-Resistant

Treatment-resistant depression (TRD) is defined as major depressive disorder that has not responded adequately to at least two antidepressant medications taken at a therapeutic dose for a sufficient duration. It is not a character flaw or a lack of effort. It reflects the neurobiological complexity of depression and the limitations of medications targeting monoamine neurotransmitter pathways.

When serotonin-based medications don't work, it often suggests the depression is being driven by circuits that SSRIs and SNRIs do not directly address. This is why TMS therapy, which directly stimulates underactive mood-regulating brain circuits, and Spravato, which targets NMDA glutamate receptors, can be effective precisely where standard antidepressants have not been.

Turnwell's board-certified psychiatrists evaluate your full medication history, previous diagnoses, and treatment responses to build a plan that moves beyond what has already been tried. For qualifying patients, advanced interventional treatments are coordinated alongside ongoing medication management and psychotherapy.

At Turnwell, Treatment Includes

Comprehensive psychiatric evaluation and diagnosis
Individualized medication management by board-certified psychiatrists
Evidence-based psychotherapy (CBT, DBT, EMDR, CPT)
Advanced interventional options (TMS, Spravato, IV ketamine) when indicated
Insurance verification and prior authorization handled by our team
Telehealth available throughout GA, SC, and FL
Advanced Treatment Options

What Turnwell Offers for Treatment-Resistant Depression

Turnwell offers the full range of evidence-based and FDA-cleared interventional options for TRD, coordinated by the same clinical team across all four locations.

FDA-Cleared

TMS Therapy

Non-invasive brain stimulation targeting underactive mood circuits. Covered by most insurance. Alpharetta GA, Charleston SC, Tampa Bay FL.

Learn about TMS
FDA-Approved

Spravato (Esketamine)

FDA-approved nasal spray for TRD. Works on NMDA glutamate receptors. Covered by most insurance. All four Turnwell locations.

Learn about Spravato
Interventional

IV Ketamine Therapy

Rapid-acting IV ketamine for TRD and PTSD. Available at Turnwell of Tampa Bay. Not typically covered by insurance.

Learn about Ketamine
Psychiatry

Medication Management

Board-certified psychiatrists evaluate your full medication history and optimize your regimen, including augmentation strategies for treatment-resistant cases.

Therapy

Psychotherapy

Individual therapy coordinated with medication management for a comprehensive approach. CBT, EMDR, and DBT available at all four locations.

Telehealth

Telehealth Options

Psychiatric evaluation and medication management available via telehealth throughout Georgia, South Carolina, and Florida for new and established patients.

If you or someone you know is in crisis, please call or text 988 (Suicide & Crisis Lifeline) or go to your nearest emergency room. Turnwell is not an emergency or crisis facility.

Call 988 Now
Frequently Asked Questions

Your Questions Answered

What is treatment-resistant depression?
Treatment-resistant depression is major depressive disorder that has not responded to at least two antidepressants at therapeutic doses for sufficient durations. About 30 percent of people with MDD experience TRD. It is not a personal failure but a biological signal that a different treatment approach is needed.
What treatments are available for TRD?
Turnwell offers TMS therapy (FDA-cleared, covered by most insurance), Spravato esketamine (FDA-approved, covered by most insurance), and IV ketamine therapy (Tampa Bay) for TRD, alongside medication management and psychotherapy.
Is TMS or Spravato covered by insurance for TRD?
Yes. Both are covered by most major insurance plans when TRD criteria are met. Coverage typically requires documentation of two failed antidepressant trials. Turnwell verifies your benefits and handles prior authorization before treatment begins.
How do I know if I qualify for TMS or Spravato?
A psychiatric evaluation at Turnwell is the starting point. Your provider reviews your antidepressant history, current symptoms, and overall picture to confirm TRD criteria and determine which option is most appropriate given your diagnosis and insurance plan.

Most Major Insurance Plans Accepted

We verify your benefits before your first appointment and handle prior authorization for TMS and Spravato.

AetnaBlue Cross Blue ShieldCignaUnited HealthcareMedicareMedicaidTricare& More

Coverage varies by plan and medical necessity criteria. Contact us to verify your specific benefits before your first appointment.

Trusted Resources

Looking for additional information about mental health conditions and treatment options? These organizations provide reliable, evidence-based guidance.

Dr. Jose I. Reyes, M.D.
Medically Reviewed By
Dr. Jose I. Reyes, M.D.
Board-Certified Psychiatrist · Turnwell Mental Health of Alpharetta
Accepting New Patients

Your Next Step Does Not Have to Feel Complicated

Our team reviews your full antidepressant history, discusses which advanced options apply to your situation, and verifies your insurance benefits before anything is scheduled. Most patients are seen within a few days of first contact. There is no obligation to commit to a specific treatment path before your evaluation.efore any treatment begins.

Scroll to Top